A Pilot Study Evaluating the Efficacy of Azithromycin, N-acetylcystein and Inhaled Corticosteroid Combination Therapy for Bronchiolitis Obliterans After Allogeneic Hematopoietic Cell Transpantation.

Trial Profile

A Pilot Study Evaluating the Efficacy of Azithromycin, N-acetylcystein and Inhaled Corticosteroid Combination Therapy for Bronchiolitis Obliterans After Allogeneic Hematopoietic Cell Transpantation.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 12 Sep 2014

At a glance

  • Drugs Acetylcysteine (Primary) ; Azithromycin (Primary) ; Corticosteroids
  • Indications Bacterial infections; Bronchiolitis obliterans
  • Focus Therapeutic Use
  • Sponsors Asan Medical Center
  • Most Recent Events

    • 15 Jan 2014 Status changed from recruiting to discontinued as reported by Clinicaltrials.gov
    • 03 Jan 2013 Planned End Date changed from 1 Apr 2013 to 1 Apr 2015 as reported by ClinicalTrials.gov.
    • 14 May 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top